Jejunal permeability and hepatic extraction of fluvastatin in humans
- 19 November 1996
- journal article
- Published by Springer Nature in Clinical Pharmacology & Therapeutics
- Vol. 60 (5) , 493-503
- https://doi.org/10.1016/s0009-9236(96)90145-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat.British Journal of Clinical Pharmacology, 1994
- By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ, 1994
- Tissue selectivity of hydroxymethylglutaryl coenzyme a (HMG CoA) reductase inhibitorsPharmacology & Therapeutics, 1993
- Anomalous parameter estimates in the one-compartment model with first-order absorptionJournal of Pharmacy and Pharmacology, 1993
- The effect of L‐leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.British Journal of Clinical Pharmacology, 1993
- Pharmacokinetics of Fluvastatin After Single and Multiple Doses in Normal VolunteersThe Journal of Clinical Pharmacology, 1992
- Disposition of pravastatin sodium, a tissue‐selective HMG‐CoA reductase inhibitor, in healthy subjects.British Journal of Clinical Pharmacology, 1990
- Physiological Disposition of Hmg-Coa-Reductase InhibitorsDrug Metabolism Reviews, 1990
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986